redefining-care_one-color
redefining-care_one-color

 

Through purpose-driven science, empowering medicines, and transformative advocacy we seek to improve the lives of millions.

Learn more »

Our areas of focus

Uterine Fibroids

An estimated 19 million women in the U.S. have uterine fibroids.

Learn more »

Endometriosis

An estimated 7.5 million premenopausal women in the U.S. have endometriosis.

Learn more »

Prostate Cancer

Approximately 3 million men alive today in the U.S. have been diagnosed with prostate cancer.

Learn more »

MYOVANT STORIES

Through storytelling, we shine a light on stigma, science, and community through videos, articles, and more.

Women's Health
What is Shared Decision Making in the Doctor’s Office?

How patients can take a more active role in their healthcare decisions.

Watch videos »

Women's Health
Menstrual Mysteries—Mothers and Daughters Talk About Periods

A video series to open up the conversation about menstruation.

Watch videos »

Endometriosis
3 Ways to Improve Diagnosis

Getting a diagnosis for endometriosis can take years. Why does this happen?

View infographic »
View more stories

PURPOSE-DRIVEN SCIENCE

purpose-driven

Myovant is developing innovative medicines that hold promise to improve people’s lives.

View our pipeline

TRANSFORMATIVE ADVOCACY

transformative-advocacy

We’re partnering with cross-sector coalitions to fight stigma, raise awareness, and empower people with information.

Learn more

Social Media

News

View more news

Events

26 Oct 2022

Myovant Sciences Q2 2022 Earnings Conference Call

13 Sep 2022

Baird 2022 Global Healthcare Conference

8 Aug 2022

MYFEMBREE FDA sNDA Approval Conference Call

27 Jul 2022

Myovant Sciences Q1 2022 Earnings Conference Call

View more events

STATEMENT

30 Jun 2022
Myovant Statement: U.S. Supreme Court Ruling in Dobbs v. Jackson Women’s Health Organization

You are leaving www.myovant.com, a website provided by Myovant Sciences GmbH.
This link will take you to a different site.

Confirm Close